Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

2022127 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 10, Issue 9, pp. 888-899

Field-Weighted Citation Impact: 12.85